Cargando…
A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma
The present study aimed to evaluate the diagnostic and prognostic value of Tat-interacting protein 30 (HTATIP2/TIP30) levels alone and in combination with α-fetoprotein (AFP) for the evaluation of hepatocellular carcinoma (HCC) patients. ELISA and immunohistochemical measurements on the serum and ti...
Autores principales: | Fan, Sha-Sha, Liao, Chu-Shu, Cao, You-De, Xiao, Pei-Ling, Deng, Tan, Luo, Rong-Cheng, Duan, Hua-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453031/ https://www.ncbi.nlm.nih.gov/pubmed/28599422 http://dx.doi.org/10.3892/ol.2017.6024 |
Ejemplares similares
-
Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
por: An, Shu, et al.
Publicado: (2023) -
Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer
por: Li, Ye-Ping, et al.
Publicado: (2018) -
Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis
por: Zhou, Kun, et al.
Publicado: (2020) -
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021) -
Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)